CTOR vs MAR · $105.2M cap vs P/E 32, rev $26.19B
Citius Oncology, Inc. (CTOR) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
CTOR does not have a complete income-statement cache yet.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
CTOR currently screens at market cap $105.2M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the CTOR and MAR stock pages for the full models.
Not investment advice.